These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34070254)
1. Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells. Podsednik A; Jiang J; Jacob A; Li LZ; Xu HN Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070254 [TBL] [Abstract][Full Text] [Related]
2. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. Grozio A; Sociali G; Sturla L; Caffa I; Soncini D; Salis A; Raffaelli N; De Flora A; Nencioni A; Bruzzone S J Biol Chem; 2013 Sep; 288(36):25938-25949. PubMed ID: 23880765 [TBL] [Abstract][Full Text] [Related]
3. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Schuster S; Penke M; Gorski T; Gebhardt R; Weiss TS; Kiess W; Garten A Biochem Biophys Res Commun; 2015 Mar; 458(2):334-40. PubMed ID: 25656579 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells. Nagaya M; Hara H; Kamiya T; Adachi T Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926 [TBL] [Abstract][Full Text] [Related]
5. Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells. Ogino Y; Sato A; Uchiumi F; Tanuma SI Genomics; 2019 Dec; 111(6):1889-1895. PubMed ID: 30582964 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil. Bi TQ; Che XM; Liao XH; Zhang DJ; Long HL; Li HJ; Zhao W Oncol Rep; 2011 Nov; 26(5):1251-7. PubMed ID: 21743967 [TBL] [Abstract][Full Text] [Related]
7. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms. Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751 [TBL] [Abstract][Full Text] [Related]
8. A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT. Barraud M; Garnier J; Loncle C; Gayet O; Lequeue C; Vasseur S; Bian B; Duconseil P; Gilabert M; Bigonnet M; Maignan A; Moutardier V; Garcia S; Turrini O; Delpero JR; Giovannini M; Grandval P; Gasmi M; Ouaissi M; Secq V; Poizat F; Guibert N; Iovanna J; Dusetti N Oncotarget; 2016 Aug; 7(33):53783-53796. PubMed ID: 27462772 [TBL] [Abstract][Full Text] [Related]
9. On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosis-mediated death in chronic lymphocytic leukemia cells. Gehrke I; Bouchard ED; Beiggi S; Poeppl AG; Johnston JB; Gibson SB; Banerji V Clin Cancer Res; 2014 Sep; 20(18):4861-72. PubMed ID: 25172933 [TBL] [Abstract][Full Text] [Related]
10. NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer. Nacarelli T; Fukumoto T; Zundell JA; Fatkhutdinov N; Jean S; Cadungog MG; Borowsky ME; Zhang R Cancer Res; 2020 Feb; 80(4):890-900. PubMed ID: 31857293 [TBL] [Abstract][Full Text] [Related]
11. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT. Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598 [TBL] [Abstract][Full Text] [Related]
12. Potential Biomarker for Triple-Negative Breast Cancer Invasiveness by Optical Redox Imaging. Feng M; Xu HN; Jiang J; Li LZ Adv Exp Med Biol; 2021; 1269():247-251. PubMed ID: 33966225 [TBL] [Abstract][Full Text] [Related]
13. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Sociali G; Raffaghello L; Magnone M; Zamporlini F; Emionite L; Sturla L; Bianchi G; Vigliarolo T; Nahimana A; Nencioni A; Raffaelli N; Bruzzone S Oncotarget; 2016 Jan; 7(3):2968-84. PubMed ID: 26658104 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation. Okumura S; Sasaki T; Minami Y; Ohsaki Y J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115 [TBL] [Abstract][Full Text] [Related]
16. NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages. Venter G; Oerlemans FT; Willemse M; Wijers M; Fransen JA; Wieringa B PLoS One; 2014; 9(5):e97378. PubMed ID: 24824795 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells. Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913 [TBL] [Abstract][Full Text] [Related]
18. Optical Redox Imaging Is Responsive to TGFβ Receptor Signalling in Triple-Negative Breast Cancer Cells. Xu HN; Jacob A; Li LZ Adv Exp Med Biol; 2022; 1395():269-274. PubMed ID: 36527648 [TBL] [Abstract][Full Text] [Related]
19. Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats. Wu GC; Liao WI; Wu SY; Pao HP; Tang SE; Li MH; Huang KL; Chu SJ Respir Res; 2017 Apr; 18(1):71. PubMed ID: 28438162 [TBL] [Abstract][Full Text] [Related]
20. Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells. Ogino Y; Sato A; Kawano Y; Aoyama T; Uchiumi F; Tanuma SI Anticancer Res; 2019 Dec; 39(12):6457-6462. PubMed ID: 31810909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]